Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary diseaseopen access
- Authors
- Jo, Yong Suk; Moon, Ji-Yong; Park, Yong Bum; Kim, Yee Hyung; Um, Soo-Jung; Kim, Woo Jin; Yoon, Hyoung Kyu; Ha Yoo, Kwang; Jung, Ki-Suck; Rhee, Chin Kook
- Issue Date
- Mar-2022
- Publisher
- BMC
- Keywords
- COPD; Blood eosinophil count; Exacerbation; Forced expiratory volume in 1 s; Longitudinal change
- Citation
- BMC PULMONARY MEDICINE, v.22, no.1, pp.1 - 8
- Indexed
- SCIE
SCOPUS
- Journal Title
- BMC PULMONARY MEDICINE
- Volume
- 22
- Number
- 1
- Start Page
- 1
- End Page
- 8
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139240
- DOI
- 10.1186/s12890-022-01873-8
- ISSN
- 1471-2466
- Abstract
- Background Data on changes in lung function in eosinophilic chronic obstructive pulmonary disease (COPD) are limited. We investigated the longitudinal changes in forced expiratory volume in 1 s (FEV1) and effects of inhaled corticosteroid (ICS) in Korean COPD patients. Methods Stable COPD patients in the Korean COPD subgroup study (KOCOSS) cohort, aged 40 years or older, were included and classified as eosinophilic and non-eosinophilic COPD based on blood counts of eosinophils (greater or lesser than 300 cells/mu L). FEV1 changes were analyzed over a 3-year follow-up period. Results Of 627 patients who underwent spirometry at least twice during the follow up, 150 and 477 patients were classified as eosinophilic and non-eosinophilic, respectively. ICS-containing inhalers were prescribed to 40% of the patients in each group. Exacerbations were more frequent in the eosinophilic group (adjusted odds ratio: 1.49; 95% confidence interval: 1.10-2.03). An accelerated FEV1 decline was observed in the non-eosinophilic group (adjusted annual rate of FEV1 change: - 12.2 mL/y and - 19.4 mL/y for eosinophilic and non-eosinophilic groups, respectively). In eosinophilic COPD, the adjusted rate of annual FEV1 decline was not significant regardless of ICS therapy, but the decline rate was greater in ICS users (- 19.2 mL/y and - 4.5 mL/y, with and without ICS therapy, respectively). Conclusions The annual rate of decline in FEV1 was favorable in eosinophilic COPD compared to non-eosinophilic COPD, and ICS therapy had no beneficial effects on changes in FEV1.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139240)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.